How Long for Herpes to Go Away After Taking Medication?

Most herpes outbreaks clear within about four to five days once antiviral medication is started, though the exact timeline depends on the type of herpes, how quickly you begin treatment, and whether you’re taking medication episodically or daily. That number may surprise people who remember outbreaks lasting a week or more before antivirals were widely prescribed. The gap between medicated and unmedicated healing is real but not as dramatic as many expect, and the biggest variable turns out to be how soon after the first symptom you take the pill.

Genital Herpes Outbreaks on Antiviral Medication

For recurrent genital herpes (HSV-2 in most cases, sometimes HSV-1), the standard episodic treatments are valacyclovir, acyclovir, or famciclovir taken for three to five days when symptoms appear. A clinical trial comparing a three-day course of valacyclovir to the traditional five-day course found that the median time to lesion healing was about four and a half days in both groups, with the overall episode lasting roughly four to four and a half days and pain resolving in two to three days.¹ That means many people see their sores close up and stop hurting in under a week. Some outbreaks are milder and resolve even faster; others, especially a first episode, can take considerably longer because the body hasn’t built up any immune response to the virus yet. First episodes often last two to three weeks even with medication.

The three approved oral antivirals for genital herpes all work through the same basic mechanism: they get converted into a compound that blocks the virus’s ability to copy its DNA. The drugs don’t kill virus that’s already sitting inside your nerve cells, but they stop it from multiplying in the skin and mucous membranes during an active outbreak. Once viral replication slows, your immune system mops up the remaining infected cells, the sore heals, and symptoms fade. All three medications produce similar healing times in head-to-head comparisons, so the choice between them usually comes down to dosing convenience and cost rather than speed.

Cold Sore Timelines on Medication

Cold sores (oral herpes, usually HSV-1) follow a slightly different treatment approach. Because people can often feel a cold sore coming on as a tingle or itch before a blister forms, treatment protocols tend to be shorter and more aggressive. Two large multicenter trials tested high-dose, short-duration valacyclovir for cold sores and found that even a single day of treatment reduced the median episode duration by a full day compared to placebo, while a two-day course shaved off about half a day.² Time to lesion healing and pain resolution were also significantly shorter with the drug than without it.

Famciclovir shows a similar pattern for cold sores. Research has found that a single dose of famciclovir works about as well as a twice-daily single-day regimen for healing lesions, and it was actually better at resolving pain and tenderness.³ The practical upside is that many cold sore sufferers can carry a single dose in a wallet or purse and take it at the first sign of a tingle, which is the window that matters most.

In practical terms, a treated cold sore typically runs its course in about four to six days. Without treatment, that same outbreak might last eight to ten days. The medication doesn’t make a cold sore vanish overnight, but it can mean the difference between a sore that lingers through a weekend versus one that stretches across a full workweek and a half.

Why Starting Early Changes Everything

The single biggest factor determining how long your outbreak lasts isn’t which drug you take or what dose. It’s when you start. All the herpes antivirals work by blocking viral replication, so they do the most good during the brief window when the virus is actively multiplying but before the immune damage to skin cells is already done. Once a blister has fully formed and ulcerated, the drug can still shorten healing somewhat, but the opportunity for the best outcome has passed.

A randomized controlled trial of valacyclovir for genital herpes quantified this clearly: people who began treatment within six hours of the first sign or symptom were nearly twice as likely to have an “aborted” episode, meaning the outbreak never progressed to a full blister at all.⁴ An aborted episode is the best possible outcome: you feel the prodromal tingling or redness, take the medication, and the lesion simply never develops. If you’ve ever heard someone say their antiviral “stopped the outbreak in its tracks,” this is probably what happened.

The practical takeaway is that having medication on hand matters at least as much as having the right medication. Doctors often prescribe antivirals in advance so patients can keep them available and start treatment at the very first hint of an outbreak, rather than losing a day or more waiting for a pharmacy visit. That lost day can be the difference between no visible sore and a five-day healing process.

Daily Suppressive Therapy and What It Does Differently

Episodic treatment is what most people think of: you feel an outbreak coming on, take pills for a few days, and the sore heals. But there’s a second strategy called suppressive therapy, where you take a lower dose of antiviral medication every single day, whether or not you’re having symptoms. Suppressive therapy isn’t primarily about making outbreaks heal faster. It’s about preventing them from happening in the first place and reducing the amount of virus your body sheds between outbreaks.

This matters because herpes can shed from the skin even when you have no sores and no symptoms. In people not taking daily medication, genital viral shedding was detected on roughly 10 to 11 percent of days in clinical trials.⁵ Daily valacyclovir cut that to about 2 to 3 percent of days across multiple studies, representing a reduction of roughly 70 to 80 percent in shedding.⁶ A landmark trial published in the New England Journal of Medicine found viral DNA in genital secretions on about 3 percent of days among people taking valacyclovir, compared to about 11 percent of days on placebo.⁷

For someone who has frequent outbreaks (more than about six per year), suppressive therapy can cut the number of recurrences in half or more, which functionally means less total time dealing with symptoms over the course of a year. It also reduces the risk of passing the virus to a partner. People on suppressive therapy who do still break through with an outbreak tend to have milder, shorter episodes because the viral load is already being kept low by the daily medication.

How Shingles Compares

Herpes simplex (HSV-1 and HSV-2) is not the same virus as herpes zoster (the varicella-zoster virus that causes shingles), but they’re related, and the same class of antiviral drugs is used for both. The healing timeline for shingles is considerably longer. A study comparing early versus late treatment of shingles found that patients treated with acyclovir within 48 hours of rash onset had a median time to complete pain resolution of 28 days, compared to 62 days for those on placebo started in the same window.⁸ With valacyclovir, median pain resolution in patients treated early was 44 days, compared to 51 for those on acyclovir alone in the same trial.

These numbers illustrate just how different the two diseases are from the patient’s perspective. A genital herpes recurrence might mean four or five uncomfortable days. A shingles episode, even with prompt treatment, often means a month or more of nerve pain. Part of this has to do with the depth of nerve involvement: shingles causes inflammation along an entire nerve branch (a dermatome), while a herpes simplex recurrence typically involves a more localized cluster of nerve endings at the skin surface. If you’re dealing with shingles and someone tells you their herpes medication cleared things up in a few days, the comparison isn’t apples to apples.

Why Herpes Never Fully “Goes Away”

The question “how long for herpes to go away” has an uncomfortable asterisk: the outbreaks go away, but the virus itself doesn’t. After an initial infection, herpes simplex virus retreats into nerve cell bodies, specifically in clusters of neurons called ganglia. Research has established that the neuron itself is the site of latent infection, where the virus parks its DNA in a dormant state that the immune system can’t reach and antiviral drugs can’t touch.⁹ The virus can reactivate from this hiding spot at any time, traveling back down the nerve to the skin surface to cause a new outbreak or to shed silently.

Antiviral medications work only on virus that is actively replicating. They have no effect on the latent virus sitting quietly inside neurons. This is why medication can shorten and prevent outbreaks but cannot cure the infection. Research into gene-editing approaches and therapeutic vaccines is ongoing, but as of now, no treatment eliminates the latent reservoir. Understanding this distinction helps set realistic expectations: “going away” in the context of herpes means the sores heal and symptoms stop, not that the virus has left your body.

When the Standard Drugs Stop Working

For most people with healthy immune systems, acyclovir, valacyclovir, and famciclovir work reliably outbreak after outbreak. But in immunocompromised individuals (people who’ve had organ transplants, those on chemotherapy, or people living with advanced HIV), the virus sometimes develops resistance to these drugs. Acyclovir-resistant herpes is uncommon in the general population but can become a serious problem in hospital and transplant settings, where outbreaks can persist for weeks or months despite standard treatment.

The main backup drug for resistant cases is foscarnet, given intravenously. The healing timelines with foscarnet are sobering. In a multicenter assessment of immunocompromised patients treated with foscarnet for acyclovir-resistant herpes, only about half of the episodes healed, and among those that did heal, the median time to lesion resolution was 38 days. Just under a quarter of episodes healed within 28 days, while the remaining cases either took far longer or never fully resolved.¹⁰ Adverse events occurred during foscarnet therapy in the vast majority of treatment episodes, with about three-quarters involving at least one drug-related side effect. A separate study of foscarnet use after stem cell transplants found that the complete healing rate from the onset of resistant herpes infection was about 31 percent by day 42 and roughly half by day 90.¹¹

These numbers are a world apart from the four-to-five-day resolution that healthy people experience. If you’re immunocompromised and your herpes outbreak isn’t responding to the standard pills after a week or so, flagging that to your medical team early is important because switching to second-line treatment sooner rather than later can prevent the kind of prolonged, painful course described in these studies.

How the Drug Actually Gets Into Your System

Valacyclovir is essentially a prodrug, meaning your body converts it into acyclovir after you swallow it. The advantage over taking plain acyclovir by mouth is better absorption: valacyclovir achieves higher blood levels with fewer daily doses. Research measuring the pharmacokinetics of the drug found that oral valacyclovir reached peak blood concentrations in a little over two hours on average, with a bioavailability of roughly 64 percent (meaning about two-thirds of the drug makes it into circulation).¹² Intravenous acyclovir, by contrast, peaks in under half an hour and delivers higher concentrations, which is why severe or resistant cases sometimes require the IV route.

For everyday outbreaks in otherwise healthy people, the oral forms work well enough. The drug is in your bloodstream within a couple of hours, and it starts suppressing viral replication shortly after. You won’t feel the sore disappearing within hours of your first dose, but by the next day or two, viral replication is being substantially curtailed. The visible healing still takes a few more days because the skin damage that already occurred needs time to repair, similar to how a cut doesn’t close instantly just because you’ve stopped the bleeding.

Topical Versus Oral Antivirals

Over-the-counter creams like docosanol and prescription topical acyclovir or penciclovir are marketed heavily for cold sores, and many people try them first because they don’t require a prescription or a doctor visit. The evidence consistently shows that oral antivirals outperform topical ones for both cold sores and genital herpes. Topical treatments deliver the drug only to the surface of the skin where you apply them, while oral antivirals reach the virus through the bloodstream, getting to nerve tissue and surrounding areas that a cream can’t penetrate.

Topical penciclovir cream, when applied every two hours while awake, can reduce cold sore duration by about half a day to a day compared to no treatment. That’s a measurable benefit, but it’s smaller and more labor-intensive than what oral valacyclovir or famciclovir achieve with one or two pills. For genital herpes, topical antivirals are essentially not recommended anymore because the oral versions are so clearly superior. If you’re managing genital herpes recurrences with a topical cream, that’s worth a conversation with your provider about switching to oral medication.

Factors That Affect Your Personal Timeline

Even with the same drug at the same dose, outbreak duration varies from person to person and outbreak to outbreak. Several factors influence how quickly you heal:

Outbreak number: First episodes are almost always the longest and most severe. Recurrences tend to get milder and shorter over time as the immune system builds familiarity with the virus.
Immune status: Stress, illness, sleep deprivation, and immunosuppressive medications can all slow healing and make outbreaks more frequent.
Location: Genital outbreaks in moist, friction-prone areas may take a day or two longer to heal than cold sores on relatively dry lip tissue, simply because of the local environment.
Treatment timing: As discussed above, starting within the first several hours of symptoms can abort the episode entirely. Starting after blisters have already formed mostly shortens the tail end of the outbreak.

People who track their outbreaks often notice that each recurrence follows a roughly predictable pattern: prodromal tingling, blister formation, ulceration, crusting, and healing. Medication compresses this timeline but doesn’t skip steps. If your outbreak feels like it’s stalled at the crusting stage, that’s usually normal healing, and the crust needs a few days to slough off on its own. Picking at it tends to delay things and can leave a mark.

What “Healed” Actually Means

In clinical trials, “healed” is usually defined as the point where the skin returns to normal or the crust falls off, whichever comes first. But patients often have a different definition in mind. You might consider yourself healed when the pain stops (which often happens a day or two before the skin looks completely normal) or when you feel comfortable being physically intimate again. For genital herpes, guidelines generally suggest waiting until sores are fully healed and no new lesions are forming before resuming sexual contact, since the risk of transmission is highest when sores are present.

It’s also worth knowing that viral shedding can continue for a short period after the skin looks healed. The visible sore is gone, but the virus may still be detectable at the site for another day or two. This is one of the reasons daily suppressive therapy is often recommended for people in serodiscordant relationships (where one partner has herpes and the other doesn’t), since it reduces shedding during both symptomatic and asymptomatic periods.

Outbreak Frequency Tends to Decline Over Time

One piece of genuinely encouraging news that many newly diagnosed people don’t hear: herpes outbreaks tend to become less frequent and less severe with time, independent of medication. The first year after diagnosis is typically the worst, with the highest number of recurrences. Over subsequent years, the immune system gets better at keeping the virus in check, and many people find that outbreaks space out from monthly to a few times a year to once a year or less. Some people eventually stop having noticeable recurrences altogether, though the virus remains latent.

This natural decline means that someone who needs suppressive therapy in their first year or two after diagnosis may eventually be able to switch to episodic treatment, keeping pills on hand for the occasional outbreak rather than taking them daily. That’s a conversation to have with a healthcare provider based on how your personal outbreak frequency evolves, but it’s reassuring to know the trajectory usually moves in the right direction.